IL169687A0 - Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable therefore - Google Patents
Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable thereforeInfo
- Publication number
- IL169687A0 IL169687A0 IL169687A IL16968705A IL169687A0 IL 169687 A0 IL169687 A0 IL 169687A0 IL 169687 A IL169687 A IL 169687A IL 16968705 A IL16968705 A IL 16968705A IL 169687 A0 IL169687 A0 IL 169687A0
- Authority
- IL
- Israel
- Prior art keywords
- poisoning
- methods
- active ingredients
- cholinesterase inhibitors
- medicaments suitable
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 239000000544 cholinesterase inhibitor Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 231100000572 poisoning Toxicity 0.000 title 1
- 230000000607 poisoning effect Effects 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10301851A DE10301851A1 (de) | 2003-01-17 | 2003-01-17 | Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel |
| PCT/EP2004/000289 WO2004064829A1 (de) | 2003-01-17 | 2004-01-16 | Verfahren zur medikamentösen prophylaxe gegen vergiftungen durch cholinesterase-hemmer, sowie hierfür geeignete wirkstoffe und arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL169687A0 true IL169687A0 (en) | 2007-07-04 |
Family
ID=32602728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL169687A IL169687A0 (en) | 2003-01-17 | 2005-07-14 | Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable therefore |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060183796A1 (enExample) |
| EP (1) | EP1585514A1 (enExample) |
| JP (1) | JP2006516267A (enExample) |
| KR (1) | KR20050104347A (enExample) |
| CN (1) | CN1741800A (enExample) |
| BR (1) | BRPI0406580A (enExample) |
| DE (1) | DE10301851A1 (enExample) |
| IL (1) | IL169687A0 (enExample) |
| WO (1) | WO2004064829A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2936150B1 (fr) * | 2008-09-19 | 2013-09-06 | Dermathologiques D Uriage Lab | Nouvelles compositions dermatologiques protectrices de la peau et des muqueuses |
| GB0809905D0 (en) * | 2008-06-02 | 2008-07-09 | Secr Defence | A Transdermal drug delivery device |
| CA3193154A1 (en) * | 2020-08-31 | 2022-03-03 | Nobelpharma Co., Ltd. | Patch for alleviating or treating symptoms of neurodegenerative disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL74497A (en) * | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
| DK0606366T3 (da) * | 1991-09-26 | 2003-10-06 | Us Gov Health & Human Serv | Substituerede phenseriner og phenylcarbamater af (-)-eserolin, (-)-N1-noreserolin og (-)-N1-benzylnoreserolin som specifikke inhibitorer af acetylcholinesterase |
| DE4342174C1 (de) * | 1993-12-10 | 1995-05-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung |
| DE4342173A1 (de) * | 1993-12-10 | 1995-06-14 | Lohmann Therapie Syst Lts | Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer |
| US5807671A (en) * | 1995-01-09 | 1998-09-15 | Yissum Research Development Company Of Hebrew University Of Jerusalem | Method of screening for genetic predisposition to anticholinesterase therapy |
| US6955819B2 (en) * | 1998-09-29 | 2005-10-18 | Zars, Inc. | Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances |
| JP4422342B2 (ja) * | 1998-11-27 | 2010-02-24 | ザノヒェミア・ファルマツォイティカ・アー・ゲー | せん妄の治療へのコリン作動性中枢神経系エフェクターの使用 |
| US6756385B2 (en) * | 2000-07-31 | 2004-06-29 | Pfizer Inc. | Imidazole derivatives |
-
2003
- 2003-01-17 DE DE10301851A patent/DE10301851A1/de not_active Withdrawn
-
2004
- 2004-01-16 BR BR0406580-8A patent/BRPI0406580A/pt not_active IP Right Cessation
- 2004-01-16 EP EP04702672A patent/EP1585514A1/de not_active Withdrawn
- 2004-01-16 JP JP2005516402A patent/JP2006516267A/ja active Pending
- 2004-01-16 CN CNA2004800024123A patent/CN1741800A/zh active Pending
- 2004-01-16 WO PCT/EP2004/000289 patent/WO2004064829A1/de not_active Ceased
- 2004-01-16 US US10/542,515 patent/US20060183796A1/en not_active Abandoned
- 2004-01-16 KR KR1020057012992A patent/KR20050104347A/ko not_active Ceased
-
2005
- 2005-07-14 IL IL169687A patent/IL169687A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0406580A (pt) | 2005-12-20 |
| KR20050104347A (ko) | 2005-11-02 |
| EP1585514A1 (de) | 2005-10-19 |
| JP2006516267A (ja) | 2006-06-29 |
| CN1741800A (zh) | 2006-03-01 |
| US20060183796A1 (en) | 2006-08-17 |
| WO2004064829A1 (de) | 2004-08-05 |
| DE10301851A1 (de) | 2004-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003244632A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| AU2003244649A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| ZA200705750B (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| EA200501586A1 (ru) | Фармацевтические продукты | |
| ZA200301813B (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them. | |
| AU2003227741A1 (en) | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| IL163831A0 (en) | Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing | |
| WO2005041925A3 (en) | Compositions and dosage forms for enhanced absorption | |
| WO2003082247A3 (en) | Drug microparticles | |
| AU2003222786A1 (en) | Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions | |
| IL183753A0 (en) | Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration | |
| IL229510A0 (en) | A dosage form containing pantoprazole as an active ingredient | |
| IL162765A (en) | Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use | |
| EP1536811A4 (en) | METHOD OF EXTRACTING AND PURIFYING THE ACTIVE INGREDIENTS OF THE I LONICERA JAPONICA / I ROD, AND THEIR USE IN ANTI-INFLAMMATORY AND ANALGESIC DRUGS | |
| AU2003300469A1 (en) | Methods for making pharmaceutical dosage forms containing active cushioning components | |
| AU2002358676A1 (en) | Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| ZA200506422B (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds | |
| AU2003246567A1 (en) | Administration form for the oral administration of active substances, vitamins, and/or nutrients | |
| EP1731609A4 (en) | INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF | |
| WO2004098577A3 (en) | Dosage form containing (s)-pantoprazole as active ingredient | |
| AU2003246566A1 (en) | Administration form for the oral administration of active substances, vitamins, and/or nutrients | |
| IL169687A0 (en) | Methods for the drug prophylaxis of poisoning by cholinesterase inhibitors, and active ingredients and medicaments suitable therefore | |
| AU2002325614A1 (en) | Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances | |
| WO2006064228A3 (en) | Thiazolopyramidine compounds for the modulation of chemokine receptor activity | |
| GEP20074183B (en) | Indazole having analgesic activity |